Name | FARMAK-APTEKA, OOO |
|---|
INN | 4632054054 |
|---|
KPP | 463201001 |
|---|
OGRN | 1054639091165 |
|---|
OKPO | 74403334 |
|---|
Address | 305023, Kurskaya Oblast', g. Kursk, ul. Litovskaya, d. D. 16 |
|---|
Phone | 6-02-65 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | All types of activities | | 70.22 | Additional activity | Advice on business and management | | 73.20 | Additional activity | Market research and public opinion polling | | 74.90 | Additional activity | Activities of professional, scientific and technical, not included in other categories |
Registration date | 04.07.2005 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po g.Kursku |
|---|
|
FARMAK-APTEKA, OOO (Kursk Oblast; INN 4632054054) was registered on 4 Jul 2005. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of FARMAK-APTEKA, OOO - Limited liability companies. Form of ownership of FARMAK-APTEKA, OOO - Private property. Principal activities of FARMAK-APTEKA, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of FARMAK-APTEKA, OOO dropped in 2023 by 7.50% to 11.63 million RUB from 12.57 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 5.81% to 255.98 million RUB from 241.92 million RUB over 2022. 2022
Net profit (RAS) of FARMAK-APTEKA, OOO dropped in 2022 by 26.86% to 12.57 million RUB from 17.19 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 5.12% to 241.92 million RUB from 254.97 million RUB in 2021. 2021
Net profit (RAS) of FARMAK-APTEKA, OOO dropped in 2021 by 17.49% to 17.19 million RUB from 20.84 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 9.53% to 254.97 million RUB from 232.79 million RUB over 2020. 2020
Net profit (RAS) of FARMAK-APTEKA, OOO grew over 2020 by 22.19% to 20.84 million RUB from 17.05 million RUB over 2019, the company informed. Revenue increased in the accounting period by 36.43% to 232.79 million RUB from 170.62 million RUB over 2019. 2018
Net profit (RAS) of FARMAK-APTEKA, OOO dropped in 2018 by 23.80% to 11.32 million RUB from 14.86 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 9.49% to 142.03 million RUB from 156.92 million RUB in 2017; cost of goods sold decreased by 8.12% to 129.52 million RUB from 140.96 million RUB; sales profit fell by 21.58% to 12.51 million RUB from 15.96 million RUB. 2017
Net profit (RAS) of FARMAK-APTEKA, OOO dropped in 2017 by 34.13% to 14.86 million RUB from 22.56 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 21.20% to 156.92 million RUB from 199.15 million RUB in 2016; cost of goods sold decreased by 19.64% to 140.96 million RUB from 175.41 million RUB; sales profit fell by 32.76% to 15.96 million RUB from 23.73 million RUB. 2016
Net profit (RAS) of FARMAK-APTEKA, OOO grew over 2016 by 7.81% to 22.56 million RUB from 20.92 million RUB over 2015, the company informed. Revenue increased in the accounting period by 10.65% to 199.15 million RUB from 179.97 million RUB over 2015; cost of goods sold grew by 11.23% to 175.41 million RUB from 157.71 million RUB; sales profit went up by 6.58% to 23.73 million RUB from 22.27 million RUB. 2014
Net profit (RAS) of FARMAK-APTEKA, OOO over 2014 was the same as in 2013 reaching 16.96 million RUB, the company informed. Revenue increased in the accounting period by 13.52% to 153.66 million RUB from 135.36 million RUB over 2013; cost of goods sold grew by 13.81% to 126.70 million RUB from 111.33 million RUB; sales profit went up by 5.99% to 18.55 million RUB from 17.50 million RUB. 2013
Net profit (RAS) of FARMAK-APTEKA, OOO grew over 2013 by 38.51% to 16.91 million RUB from 12.21 million RUB over 2012, the company informed. Revenue increased in the accounting period by 31.16% to 135.36 million RUB from 103.21 million RUB over 2012; cost of goods sold grew by 32.05% to 111.33 million RUB from 84.30 million RUB; sales profit went up by 41.56% to 17.50 million RUB from 12.36 million RUB. 2012
Net profit (RAS) of FARMAK-APTEKA, OOO grew over 2012 by 1.98% to 12.12 million RUB from 11.89 million RUB over 2011, the company informed. Revenue increased in the accounting period by 5.29% to 103.21 million RUB from 98.02 million RUB over 2011; cost of goods sold grew by 5.59% to 90.66 million RUB from 85.86 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|